信息搜索
信息关键字:医药
 

共有1868条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94]

·医药商业股持续拉升,瑞康医药、嘉事堂、南京医药、中国医药、人民同泰涨停,上海医药、药易购等跟涨2022-3-31 10:34:48
·新冠药概念股震荡走强中国医药再度涨停2022-3-31 9:52:57
·券商晨会精华:十四五中医药发展规划发布,引领中药行业高质量前进,目前该行业已经具备一定估值弹性2022-3-31 8:53:54
·吉林所有确诊病例使用中医药治疗中医在新冠防治中不可或缺2022-3-31 7:58:38
·上海医药2021年报:营收突破2100亿,净利润超50亿2022-3-30 20:23:00
·复盘90涨停股:中国医药2连板农发种业断板九安医疗尾盘炸板2022-3-30 16:27:56
·中医药行业点评:《“十四五”中医药发展规划》重磅出台利好中医药行业关注中药+中医服务公司2022-3-30 16:19:49
·91只个股涨停主要集中在房地产、医药生物等行业2022-3-30 15:54:14
·民生证券:中医药正式迈入高质量发展阶段行业打开中长期想象空间2022-3-30 15:12:19
·医药生物行业:《“十四五”中医药发展规划》发布行业景气度值得期待2022-3-30 15:00:14
·医药生物行业事件点评:合力共同推动中医药振兴发展2022-3-30 14:49:48
·工银瑞信基金赵蓓:香港生物医药板块进入估值相对合理阶段2022-3-30 13:46:09
·上海医药2021年净利50.93亿同比增长13.28%财务总监沈波薪酬543.44万2022-3-30 11:10:33
·新冠药概念股反复活跃中国医药3月大涨265%2022-3-30 10:36:33
·国务院印发《“十四五”中医药发展规划》中药创新药或迎来爆发2022-3-30 9:01:35
·“十四五”中医药发展规划发布明确十大任务!机构建议关注四大赛道2022-3-30 7:46:01
·借力资本市场“抗疫”科创板生物医药公司彰显“硬科技”底色2022-3-30 7:37:41
·森萱医药2021年净利1.31亿同比减少9.38%财务费用下降2022-3-29 22:19:58
·晚间资讯:最豪“10转8”,多家公司拟“高送转”;“十四五”中医药发展规划印发2022-3-29 22:06:39
·森萱医药总经理袁拥军上任首份成绩单:公司去年净利润下滑系七年来首次2022-3-29 20:26:23

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94]